Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Collagen Matrix Inc. has 5 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 distinct examiners and 4 distinct art units, showing a distributed docket with one additional matter beyond the examiner and art-unit counts.
PARK, HAEJIN S is the busiest examiner, with 2 pending matters. That allocation provides one point for coordinated examiner-specific review, while the other assignments require separate technical and procedural tracking.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 3 (60%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PARK, HAEJIN S | 2 | 55.1% | +38.3% |
| LONG, SARAH A | 1 | 60.7% | +42.4% |
| IANNUZO, NATALIE NMN | 1 | 12.2% | +71.4% |
| LIEB, JEANETTE M | 1 | 79.8% | +17.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18776892 | COMPRESSION AND KINK RESISTANT IMPLANTS | LONG, SARAH A | 15d overdue |
| 18025963 | COLLAGEN WITH SELECTIVE CHARACTERISTICS, COLLAGEN PRODUCTS CONTAINING SAME AND METHODS FOR PRODUCING SAME | IANNUZO, NATALIE NMN | 12d |
| 18091782 | COLLAGEN WITH SELECTIVE CHARACTERISTICS, COLLAGEN PRODUCTS CONTAINING SAME AND METHODS FOR PRODUCING SAME | LIEB, JEANETTE M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18776892 | COMPRESSION AND KINK RESISTANT IMPLANTS | LONG, SARAH A | 15d overdue |
| 18025963 | COLLAGEN WITH SELECTIVE CHARACTERISTICS, COLLAGEN PRODUCTS CONTAINING SAME AND METHODS FOR PRODUCING SAME | IANNUZO, NATALIE NMN | 12d |
| 18091782 | COLLAGEN WITH SELECTIVE CHARACTERISTICS, COLLAGEN PRODUCTS CONTAINING SAME AND METHODS FOR PRODUCING SAME | LIEB, JEANETTE M | — |
| 17472897 | BONE GRAFT SUBSTITUTE | PARK, HAEJIN S | — |
| 17234365 | BONE GRAFT SUBSTITUTE | PARK, HAEJIN S | — |
| Art Unit | Apps |
|---|---|
| 1614 | 2 |
| 3771 | 1 |
| 1653 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18776892 | COMPRESSION AND KINK RESISTANT IMPLANTS | LONG, SARAH A | 3771 | §103§112 | Non-Final OA | 15d overdue | Pending | Jul 18, 2024 |
| 18025963 | COLLAGEN WITH SELECTIVE CHARACTERISTICS, COLLAGEN PRODUCTS CONTAINING SAME AND METHODS FOR PRODUCING SAME | IANNUZO, NATALIE NMN | 1653 | §102§103§112DP | Final Rejection | 12d | Pending | Mar 13, 2023 |
| 18091782 | COLLAGEN WITH SELECTIVE CHARACTERISTICS, COLLAGEN PRODUCTS CONTAINING SAME AND METHODS FOR PRODUCING SAME | LIEB, JEANETTE M | 1654 | §102§103§112Other | Non-Final OA | — | Pending | Dec 30, 2022 |
| 17472897 | BONE GRAFT SUBSTITUTE | PARK, HAEJIN S | 1614 | §103§112DP | Non-Final OA | — | Pending | Sep 13, 2021 |
| 17234365 | BONE GRAFT SUBSTITUTE | PARK, HAEJIN S | 1614 | §103§112DP | Non-Final OA | — | Pending | Apr 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCollagen Matrix Inc. has 5 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Haejin S Park has the most, with 2 of Collagen Matrix Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
